Answers are grounded in this paper and cite their sources.
In this 6-month trial involving patients with type 1 diabetes, the use of a closed-loop system was associated with a greater percentage of time spent in a target glycemic range than the use of a sensor-augmented insulin pump. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases; iDCL ClinicalTrials.gov number, NCT03563313.).
No takes yet. Share an insight, caveat, or question.
Brown et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: